Use the right tool for the right job!

Slides:



Advertisements
Similar presentations
Hemodynamic Monitoring
Advertisements

The golden hour(s) for severe sepsis and septic shock treatment
Measurement of pulmonary gas exchange in the ICU. Stephen Rees Center for Model-based Medical Decision Support, Department of Health Science and Technology,
Mechanical Ventilaton Ramon Garza III, M.D.. Indications Airway instability Most surgical patients or trauma Primary Respirator Failure Mostly medical.
Weaning failure of cardiac origin
M. Dres, J-L. Teboul, N. Anguel, L. Guerin, C. Richard, X. Monnet
The New Surviving Sepsis Bundles: From Time Zero to Tomorrow
Haemodynamic Monitoring
PVI Overview Physiology Fluid administration challenges PVI method
Dr. Abdul-Monim Batiha Monitoring in Critical Care Dr. Abdul-Monim Batiha.
Hemodynamic monitoring
Compliance with Severe Sepsis Protocol: Impact on Patient Outcomes Lisa Hurst RN BSN CCRN and Kim Raines RN CCRN References The purpose of this study is.
Sepsis Protocol Go Live December 1, 2009 Hendricks Regional Health.
Potential Applications
FROM CEM SEPSIS TOOLKIT PAPERS TO COVER NGUYEN EARLY LACTATE CLEARANCE IS ASSOCIATED WITH IMPROVED OUTCOME IN SEVERE SEPSIS AND SEPTIC SHOCK P Single.
Optimal fluid resuscitation: Lactate?
Sepsis.
Fluid Resuscitation 2013 NH.  Benefits  Problems  Which fluid?  Assessing volume status  Preload/Volume Status  Contractility  Afterload/ Vascular.
A REVIEW OF FUNCTIONAL HAEMODYNAMIC MONITORING AJ van den Berg.
Haemodynamic Monitoring
Set your intravascular volume right Jost Mullenheim James Cook University Hospital, Middlesbrough.
Haemodynamic Monitoring Theory and Practice. 2 Haemodynamic Monitoring A.Physiological Background B.Monitoring C.Optimising the Cardiac Output D.Measuring.
Chapter 15 Assessment of Cardiac Output
Hemodynamic monitoring Prof. Jean-Louis TEBOUL University Paris-South
Pressure, Flow, and Resistance Understanding the relationship among pressure, flow and resistance can help you understand how cardiac output and vascular.
Hemodynamic Monitoring By Nancy Jenkins RN,MSN. What is Hemodynamic Monitoring? It is measuring the pressures in the heart.
The Vexing Problem of Vasoplegia
Protective Lung Strategy Mazen Kherallah, MD, FCCP
Circulatory Failure 6 th November Physiology and pathophysiology of the heart and circulation Pathophysiological effects of altered intravascular.
Peri-operative haemodynamic therapy: The OPTIMISE trial Rupert Pearse Senior Lecturer in Intensive Care Medicine William Harvey Research Institute Barts.
Wet, Dry, or Even? Some Ways of Looking at Volume Status without a Pulmonary-Arterial Catheter Anne K. Sutherland, MD Critical Care Medicine St. Barnabas.
Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris XI France What is the best way to assess What is the best way to assess fluid responsiveness.
Techniques for the Future: Continuity versus Accuracy?
Monitoring Fluid Responsiveness Murat Sungur, MD Erciyes University Medical School Department of Medicine Division of Critical Care Medicine.
Haemodynamic Monitoring Theory and Practice. 2 Haemodynamic Monitoring A.Physiological Background B.Monitoring C.Optimizing the Cardiac Output D.Measuring.
Haemodynamic Monitoring Theory and Practice. 2 Haemodynamic Monitoring A.Physiological Background B.Monitoring C.Optimising the Cardiac Output D.Measuring.
Richard Siebert. EVLW Extravasular lung water measures fluid in the pulmonary interstitium, alveoli and intracellular space but not pleural effusions.
Chapter 16 Assessment of Hemodynamic Pressures
Physiologic Basis for Hemodynamic Monitoring 臺大醫院麻醉部 鄭雅蓉.
Are The Less Invasive Techniques For Monitoring Cardiac Output As Accurate As The Pulmonary Artery Catheter? Dr Andrew Rhodes St George’s Hospital London.
Hemodynamic optimization in intra- abdominal hypertension Jan J. De Waele MD PhD Surgical ICU Ghent University Hospital Ghent, Belgium.
Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris-South France Optimal blood pressure target in septic shock.
Echocardiography in ICU Michel Slama AmiensFrance LEVEL 1 basic LEVEL 2: advanced.
ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.
Respiratory Respiratory Failure and ARDS. Normal Respirations.
Christian RICHARD Bicêtre Hospital AP- HP PARIS XI University FRANCE Which shocked patients should be monitored with a pulmonary artery catheter and does.
นพ. ธรรมศักดิ์ ทวิช ศรี หน่วยเวชบำบัด วิกฤต ฝ่ายวิสัญญีวิทยา รพ. จุฬาลงกรณ์
COMBINED USE OF TRANSPULMONARY THERMODILUTION (TPTD) TECHNIQUE IN FLUID MANAGEMENT FOR SEPSIS PATIENTS 1 St. Marianna University School of Medicine, Kanagawa,
Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris South France Challenge in Right Heart Failure.
Cardiac Output Monitoring
3 rd iFAD 29/11/2013 Non-invasive hemodynamic monitoring 1 P16: Non-invasive hemodynamic monitoring with Nexfin in critically ill patients: a preliminary.
Fluid responsiveness Prof. Xavier MONNET
PulseCO Monitoring System. Estimates of Preload Clinical: BP, HR, capillary refill, urine Postural changes CVP PAC Echo.
Prof.Mehdi H MUMTAZ FLUID THERAPY ;It is the first weapon in the armoury of physcian to counter hypovolaemia or shock; ;Uncorrected hypovolaemia with.
Hemodynamic Monitoring John Nation RN, MSN Thanks to Nancy Jenkins.
Acute Respiratory Distress Syndrome
Functional Hemodynamic Monitoring NEANA Spring Meeting April 2016 Donna Adkisson, R.N., M.S.N. Clinical Educator LiDCO, Limited.
The Potential of Non-Invasive Goal Directed Therapy Maxime CANNESSON MD PhD Associate Professor Department of Anesthesiology & Perioperative Care University.
경희대 호흡기내과 ACUTE RESPIRATORY DISTRESS SYNDROME (Update 2013) 호흡기내과 박명재.
Hemodynamic Monitoring in the Critical Care Environment
Objectives Describe the cardiovascular monitoring techniques used in the care of critically ill patients and how to interpret the results of hemodynamic.
Flow Monitoring Approaches
高風險手術患者麻醉中的血液動力學分析 Hemodynamic optimization for high risk surgical patients 三軍總醫院麻醉部 呂忠和醫師.
Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other.
Capillary Albumin Transudation Rate and Outcome in Critically Ill Subjects Stephanie Yan, MD, Colin Doyle, MD, David Inouye, MD, Scott Harvey, MD, Michael.
Simon Tilma Vistisen Associate Professor
Transpulmonary indicator dilution method
Uncalibrated pulse contour-derived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation 
Objectives: Identify a patient in shock
Hemodynamic Monitoring in the Critical Care Environment
Presentation transcript:

Use the right tool for the right job! Assessment of fluid therapy Use the right tool for the right job! Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE

Conflict of interest Pulsion Medical Systems

Use the right tool for the right job! Assessment of fluid therapy Use the right tool for the right job! Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE

?   Differents monitoring devices Different indications AP CVP PAC PiCCO Nexfin ProAQT/PulsioFlex Esophageal Doppler FloTrac/Vigileo Echo  Differents monitoring devices ?  Different indications

Peri-op monitoring   Peri-op monitoring ICU monitoring

Peri-op monitoring Context High-risk surgical patients (except cardiac surgery) Goals of monitoring to detect hemodynamic deterioration to guide volume expansion Improves prognosis

Peri-op monitoring Improves prognosis with esophageal Doppler 60 patients hip replacement  hospital length of stay 100 high-risk surgical patients  hospital length of stay 174 patients post cardiac surgery  hospital length of stay 162 multiple trauma patients after surgery hospital length of stay ICU length of stay lactate level

Peri-op monitoring Improves prognosis with LidCO 60-risk general surgical patients Goal directed therapy vs. conventional treatment Post-operative phase  number of complications  hospital length of stay 120 high-risk abdominalsurgery patients SVV-directed therapy vs. conventional treatment Per-operative phase LidCO monitoring  number of complications  hospital length of stay

Peri-op monitoring Improves prognosis with Flotrac/Vigileo 40 patients with hip replacement under regional anesthesia Goal directed therapy vs. conventional treatment  number of complications

Peri-op monitoring LidCOrapid Vigileo Pulsioflex Eso Doppler continuous cardiac output continuous cardiac output continuous cardiac output continuous cardiac output (AP curve analysis) (AP curve analysis) (AP curve analysis) (cardiac output) preload dependance (VVE and Δ PP) preload dependance (VVE and Δ PP) preload dependance (VVE and Δ PP) preload dependance (Δ aortic blood flow) preload (FTc)

  OR monitoring ICU monitoring Basic monitoring Advanced monitoring Arterial pressure CVP Esophageal Doppler Flotrac/Vigileo Pulsioflex LidCOrapid PiCCO EV 1000 PA catheter

Basic ICU monitoring  Context initial phase of shock after the ER Objectives of monitoring assess the hemodynamic profile (type of shock) guide initial therapy fix some therapeutic goals  Which basic monitoring?

Basic ICU monitoring

Basic ICU monitoring CVP Arterial pressure DAP PPV MAP Helps for: determining the type of shock (preload) deciding to give vasopressors guiding fluid responsiveness (preload) deciding to give fluid (if ventilated) PPV MAP fixing some therapeutic goals

  ? ? OR monitoring ICU monitoring Basic monitoring Advanced monitoring Arterial pressure ? CVP ? Esophageal Doppler Flotrac/Vigileo Pulsioflex LidCOrapid PiCCO EV 1000 PA catheter

Advanced ICU monitoring Context critically ill patients when shock persists after initial fluid therapy The only arterial pressure and CVP monitoring is not sufficient anymore because patients receive vasopressors

Advanced ICU monitoring 228 pts receiving volume expansion 145 patients with increase of NE * r = 0.56 n = 228 r = 0.21 n = 145 -50 50 100 150 200 250 300 Changes in CI induced by VE (%) Changes in PP induced by VE (%) -50 50 100 150 200 250 300 Changes in CI induced by NE (%) Changes in PP induced by NE (%)

Advanced ICU monitoring 228 pts receiving volume expansion 145 patients with increase of NE -20 20 40 60 80 100 non responders responders changes in CI (%) -20 20 40 60 80 100 non responders responders changes in PP (%) 6% false + +15% 22% false -

Advanced ICU monitoring LidCOrapid Vigileo Pulsioflex Eso Doppler continuous cardiac output AP curve analysis uncalibrated continuous cardiac output continuous cardiac output AP curve analysis uncalibrated continuous cardiac output continuous cardiac output AP curve analysis uncalibrated continuous cardiac output continuous cardiac output (AP curve analysis) (AP curve analysis) (AP curve analysis) (cardiac output) preload dependance (VVE and Δ PP) preload dependance (VVE and Δ PP) preload dependance (VVE and Δ PP) preload dependance (Δ aortic blood flow) preload (FTc)

? Advanced ICU monitoring Which device for advanced monitoring? Uncalibrated devices 20 40 60 80 100 120 estimate SV from the arterial pressure curve estimate arterial compliance by analysing the arterial waveform = k . SV still valuable when the properties of the arterial curve change in a large extent (sepsis, vasopressors) ?

arterial pressure curve Advanced ICU monitoring Which device for advanced monitoring? PiCCO and EV1000 devices measure cardiac output by arterial pressure curve analysis 3.5 L/min

arterial pressure curve Advanced ICU monitoring Which device for advanced monitoring? PiCCO and EV1000 devices measure cardiac output by arterial pressure curve analysis cold bolus calibrated by transpulmonary thermodilution inj Blood temperature (Ts) Ttm

Advanced ICU monitoring Which device for advanced monitoring? Ability to track calibrated cardiac index changes induced by volume expansion (40 patients) PiCCO changes induced by norepinephrine (40 patients) Vigileo2 uncalibrated cardiac index

Advanced ICU monitoring Which device for advanced monitoring? Changes induced by volume expansion -15 15 30 45 60 75 D CItd (%) r = 0.78 p < 0.05 PiCCO r = -0.03 p = NS 90 105 120 Vigileo2 Changes induced by norepinephrine PiCCO r = 0.72 p < 0.05 -15 15 30 45 60 75 90 105 120 D CIpc (%) DCItd (%) Vigileo2 r = 0.33 CIpw (%) CItd (%)  

Advanced ICU monitoring Which device for advanced monitoring? 51 pts, 401 measurements Vigileo2 vs.Vigileo3 vs. PAC Vigileo3 is more accurate and as precise than Vigileo2

Advanced ICU monitoring Which device for advanced monitoring? 33 patients Vigileo3 vs. esophageal Doppler Hemodynamic challenges by phenylephrine, ephedrine and whole-body tilting

Advanced ICU monitoring Which device for monitoring cardiac output? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output

Advanced ICU monitoring Context critically ill patients when shock persists after initial fluid therapy Goals of monitoring precisely monitor the effects of therapy fix some therapeutic goals predict fluid responsiveness assess the risk of fluid expansion

Advanced ICU monitoring How to assess the need for fluid? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output SvO2 ScvO2 ScvO2

Advanced ICU monitoring Context critically ill patients when shock persists after initial fluid therapy Goals of monitoring precisely monitor the effects of therapy fix some therapeutic goals predict fluid responsiveness assess the risk of fluid expansion

Advanced ICU monitoring How to assess the need for fluid? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output PAOP PPV, SVV, PLR test, EEO test PPV, SVV, PLR test, EEO test SvO2 ScvO2 ScvO2

Advanced ICU monitoring How to assess the need for fluid?

Advanced ICU monitoring How to assess the need for fluid? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output continuous continuous PAOP PPV, SVV, PLR test, EEO test PPV, SVV, PLR test, EEO test SvO2 ScvO2 ScvO2

Advanced ICU monitoring How to assess the need for fluid? venous return

Advanced ICU monitoring How to assess the need for fluid? Effects of end-expiratory pause on cardiac index 34 patients with acute circulatory failure monitored by PiCCO device 50 40 30 20 increase  5% Se = 91% Sp = 100 % 10 -10 NR R

Advanced ICU monitoring How to assess the need for fluid?

Advanced ICU monitoring Context critically ill patients when shock persists after initial fluid therapy Goals of monitoring precisely monitor the effects of therapy fix some therapeutic goals predict fluid responsiveness assess the risk of fluid expansion

Advanced ICU monitoring How to assess the risk of volume expansion? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output PAOP PPV, SVV, PLR test, EEO test PPV, SVV, PLR test, EEO test SvO2 ScvO2 ScvO2 lung water and lung permeability lung water and lung permeability

Advanced ICU monitoring How to assess the risk of volume expansion? Lung permeability lung water very high permeability normal permeability high permeability lung water Pcap Pcap

Advanced ICU monitoring Lung water for estimating the risk of volume expansion? Lung permeability Lung water very high permeability normal permeability high permeability lung water lung water Pcap Pcap

Advanced ICU monitoring Lung water for estimating the risk of volume expansion? Cold bolus PiCCO EV1000

Advanced ICU monitoring Lung water for estimating the risk of volume expansion? 30 pts EVLW measured by TPTD and by postmortem gravimetry First validation of EVLW-TPTD evaluation in humans → validation in human beings

Advanced ICU monitoring Lung water for estimating the risk of volume expansion?

Advanced ICU monitoring Lung water for estimating the risk of volume expansion? Extra-vascular lung water and pulmonary vascular permeability index are independent prognostic factors in patients with acute respiratory distress syndrome Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X submitted 200 pts with ARDS EVLW measured by PiCCO device 20 40 60 80 100 EVLWImax > 21 mL/kg EVLWImax ≤ 21 mL/kg 70% 42% p = 0.0001 Day-28 mortality (%) p value Maximal blood lactate 0.81 (0.71 - 0.93) 0.002 Mean PEEP 1.25 (1.07 - 1.47) 0.005 EVLWI max 0.94 (0.87 - 0.98) 0.01 SAPS II 0.97 (0.95 - 0.99) 0.02 Mean fluid balance 0.9996 ( 0.9993 - 0.9999) Minimal P/F ratio 1.01 (1.00 - 1.02) Minimal pH 35.97 (0.47 - 2769.52) 0.10 Odds Ratio ( CI 95%)

Advanced ICU monitoring Lung water for estimating the risk of volume expansion? Cumulative fluid balance (input - output; L) 7 * * PAOP group * 5 * 3 1 EVLW group -1 -3 * p < 0.0001 vs time 0 -5 0 12 24 36 48 60 72 Time (hours) 101 ARDS patients randomized to EVLW-guided management vs. PAOP-guided management Mitchell JP et al., Am Rev Respir Dis 1992

Advanced ICU monitoring Lung water for estimating the risk of volume expansion?  functional benefit of lung water monitoring 25 20 15 Management of fluid therapy with : * * 10 PAOP Group 5 EVLW Group Ventilation days ICU days 101 ARDS patients randomized to EVLW-guided management vs. PAOP-guided management Mitchell JP et al., Am Rev Respir Dis 1992

Advanced ICU monitoring Lung water for estimating the risk of volume expansion Lung permeability Lung water very high permeability normal permeability high permeability lung water lung water Pcap Pcap

pulmonary blood volume Advanced ICU monitoring Lung permeability for estimating the risk of volume expansion? PVPI lung water pulmonary vascular permeability index = pulmonary blood volume cold bolus PiCCO EV1000

Advanced ICU monitoring Lung permeability for estimating the risk of volume expansion? PVPI 1 2 3 4 5 6 7 8 9 10 48 patients with pulmonary edema inflammatory vs. hydrostatic discriminated by experts PVPI by the PiCCO device Cut-off : 3 Se = 85 % Sp = 100 % * ALI/ARDS Hydrostatic pulmonary edema

Advanced ICU monitoring Lung permeability for estimating the risk of volume expansion? ARDS AP = 90 / 40 mmHg Cardiac index = 2.0 L/min/m2 PaO2/FiO2 = 180 mmHg PLR test : positive ARDS AP = 90 / 40 mmHg Cardiac index = 2.0 L/min/m2 PaO2/FiO2 = 180 mmHg PLR test : positive PVPI = 4 PVPI= 7 volume expansion volume expansion vasopressors?

Advanced ICU monitoring Lung permeability for estimating the risk of volume expansion? PA catheter PiCCO EV 1000 cardiac output cardiac output cardiac output PAOP PPV, VVE, PLR test, EEO test PPV, VVE, PLR test, EEO test SvO2 ScvO2 ScvO2 lung water and lung permeability lung water and lung permeability

!   Differents monitoring devices Different indications AP CVP PAC PiCCO Nexfin ProAQT/PulsioFlex Esophageal Doppler FloTrac/vigileo Echo  Differents monitoring devices !  Different indications

  OR monitoring ICU monitoring Basic monitoring Advanced monitoring Arterial pressure CVP Esophageal Doppler Flotrac/Vigileo Pulsioflex LidCOrapid PiCCO EV 1000 PA catheter